Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
KRO vs EMN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
KRO vs EMN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $811M | $8.43B |
| Revenue (TTM) | $1.88B | $8.64B |
| Net Income (TTM) | $-134M | $399M |
| Gross Margin | 10.1% | 19.8% |
| Operating Margin | -3.1% | 9.4% |
| Forward P/E | — | 12.5x |
| Total Debt | $577M | $5.08B |
| Cash & Equiv. | $37M | $566M |
KRO vs EMN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Kronos Worldwide, I… (KRO) | 100 | 72.2 | -27.8% |
| Eastman Chemical Co… (EMN) | 100 | 108.2 | +8.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KRO vs EMN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
KRO is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth -1.5%, EPS growth -228.0%, 3Y rev CAGR -1.2%
- 129.0% 10Y total return vs EMN's 35.4%
- Lower volatility, beta 1.57, Low D/E 76.9%, current ratio 2.70x
EMN carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 12 yrs, beta 1.36, yield 4.5%
- Beta 1.36, yield 4.5%, current ratio 1.37x
- 4.6% margin vs KRO's -7.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -1.5% revenue growth vs EMN's -6.7% | |
| Quality / Margins | 4.6% margin vs KRO's -7.1% | |
| Stability / Safety | Beta 1.36 vs KRO's 1.57 | |
| Dividends | 4.5% yield, 12-year raise streak, vs KRO's 2.8% | |
| Momentum (1Y) | +2.3% vs KRO's -1.2% | |
| Efficiency (ROA) | 2.6% ROA vs KRO's -9.4%, ROIC 6.7% vs -1.9% |
KRO vs EMN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
KRO vs EMN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
EMN leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMN is the larger business by revenue, generating $8.6B annually — 4.6x KRO's $1.9B. EMN is the more profitable business, keeping 4.6% of every revenue dollar as net income compared to KRO's -7.1%. On growth, KRO holds the edge at +4.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.9B | $8.6B |
| EBITDAEarnings before interest/tax | -$9M | $1.2B |
| Net IncomeAfter-tax profit | -$134M | $399M |
| Free Cash FlowCash after capex | $35M | $498M |
| Gross MarginGross profit ÷ Revenue | +10.1% | +19.8% |
| Operating MarginEBIT ÷ Revenue | -3.1% | +9.4% |
| Net MarginNet income ÷ Revenue | -7.1% | +4.6% |
| FCF MarginFCF ÷ Revenue | +1.9% | +5.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.1% | -4.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -126.1% | -40.8% |
Valuation Metrics
KRO leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, EMN's 9.0x EV/EBITDA is more attractive than KRO's 40.7x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $811M | $8.4B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $12.9B |
| Trailing P/EPrice ÷ TTM EPS | -7.34x | 17.97x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.50x |
| PEG RatioP/E ÷ EPS growth rate | — | 5.59x |
| EV / EBITDAEnterprise value multiple | 40.71x | 8.96x |
| Price / SalesMarket cap ÷ Revenue | 0.44x | 0.96x |
| Price / BookPrice ÷ Book value/share | 1.08x | 1.41x |
| Price / FCFMarket cap ÷ FCF | — | 19.87x |
Profitability & Efficiency
EMN leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
EMN delivers a 6.7% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-17 for KRO. KRO carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMN's 0.84x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -17.0% | +6.7% |
| ROA (TTM)Return on assets | -9.4% | +2.6% |
| ROICReturn on invested capital | -1.9% | +6.7% |
| ROCEReturn on capital employed | -2.2% | +7.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.77x | 0.84x |
| Net DebtTotal debt minus cash | $540M | $4.5B |
| Cash & Equiv.Liquid assets | $37M | $566M |
| Total DebtShort + long-term debt | $577M | $5.1B |
| Interest CoverageEBIT ÷ Interest expense | -2.32x | 2.22x |
Total Returns (Dividends Reinvested)
EMN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EMN five years ago would be worth $7,163 today (with dividends reinvested), compared to $5,607 for KRO. Over the past 12 months, EMN leads with a +2.3% total return vs KRO's -1.2%. The 3-year compound annual growth rate (CAGR) favors EMN at 1.1% vs KRO's -0.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +58.5% | +15.8% |
| 1-Year ReturnPast 12 months | -1.2% | +2.3% |
| 3-Year ReturnCumulative with dividends | -0.7% | +3.4% |
| 5-Year ReturnCumulative with dividends | -43.9% | -28.4% |
| 10-Year ReturnCumulative with dividends | +129.0% | +35.4% |
| CAGR (3Y)Annualised 3-year return | -0.2% | +1.1% |
Risk & Volatility
Evenly matched — KRO and EMN each lead in 1 of 2 comparable metrics.
Risk & Volatility
EMN is the less volatile stock with a 1.36 beta — it tends to amplify market swings less than KRO's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.57x | 1.36x |
| 52-Week HighHighest price in past year | $7.90 | $84.18 |
| 52-Week LowLowest price in past year | $4.08 | $56.11 |
| % of 52W HighCurrent price vs 52-week peak | +89.2% | +87.5% |
| RSI (14)Momentum oscillator 0–100 | 63.4 | 56.9 |
| Avg Volume (50D)Average daily shares traded | 350K | 1.5M |
Analyst Outlook
EMN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates KRO as "Hold" and EMN as "Buy". Consensus price targets imply 4.9% upside for EMN (target: $77) vs -29.1% for KRO (target: $5). For income investors, EMN offers the higher dividend yield at 4.47% vs KRO's 2.84%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $5.00 | $77.29 |
| # AnalystsCovering analysts | 7 | 35 |
| Dividend YieldAnnual dividend ÷ price | +2.8% | +4.5% |
| Dividend StreakConsecutive years of raises | 0 | 12 |
| Dividend / ShareAnnual DPS | $0.20 | $3.30 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.2% |
EMN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). KRO leads in 1 (Valuation Metrics). 1 tied.
KRO vs EMN: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is KRO or EMN a better buy right now?
For growth investors, Kronos Worldwide, Inc.
(KRO) is the stronger pick with -1. 5% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate Eastman Chemical Company (EMN) a "Buy" — based on 35 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — KRO or EMN?
Over the past 5 years, Eastman Chemical Company (EMN) delivered a total return of -28.
4%, compared to -43. 9% for Kronos Worldwide, Inc. (KRO). Over 10 years, the gap is even starker: KRO returned +129. 0% versus EMN's +35. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — KRO or EMN?
By beta (market sensitivity over 5 years), Eastman Chemical Company (EMN) is the lower-risk stock at 1.
36β versus Kronos Worldwide, Inc. 's 1. 57β — meaning KRO is approximately 16% more volatile than EMN relative to the S&P 500. On balance sheet safety, Kronos Worldwide, Inc. (KRO) carries a lower debt/equity ratio of 77% versus 84% for Eastman Chemical Company — giving it more financial flexibility in a downturn.
04Which is growing faster — KRO or EMN?
By revenue growth (latest reported year), Kronos Worldwide, Inc.
(KRO) is pulling ahead at -1. 5% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Eastman Chemical Company grew EPS -46. 5% year-over-year, compared to -228. 0% for Kronos Worldwide, Inc.. Over a 3-year CAGR, KRO leads at -1. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — KRO or EMN?
Eastman Chemical Company (EMN) is the more profitable company, earning 5.
4% net margin versus -6. 0% for Kronos Worldwide, Inc. — meaning it keeps 5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMN leads at 10. 6% versus -1. 7% for KRO. At the gross margin level — before operating expenses — EMN leads at 21. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is KRO or EMN more undervalued right now?
Analyst consensus price targets imply the most upside for EMN: 4.
9% to $77. 29.
07Which pays a better dividend — KRO or EMN?
All stocks in this comparison pay dividends.
Eastman Chemical Company (EMN) offers the highest yield at 4. 5%, versus 2. 8% for Kronos Worldwide, Inc. (KRO).
08Is KRO or EMN better for a retirement portfolio?
For long-horizon retirement investors, Eastman Chemical Company (EMN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (4.
5% yield). Kronos Worldwide, Inc. (KRO) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EMN: +35. 4%, KRO: +129. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between KRO and EMN?
Both stocks operate in the null sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: KRO is a small-cap quality compounder stock; EMN is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.